Optimizing RNA extraction methods for high-throughput transcriptome sequencing of formalin-fixed paraffin-embedded cardiac tissue specimens
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0315098 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Nkechi Martina Odogwu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Rochester, Rochester, Minnesota, United States of America. Hauptthemen laut MEDLINE: Formaldehyde, High-Throughput Nucleotide Sequencing, Paraffin Embedding, RNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mayo Foundation for Medical Education and Research.
Abstract (Originalsprache)
Archived FFPE cardiac tissue specimens are valuable for molecular studies aimed at identifying biomarkers linked to mortality in cardiovascular disease. Establishing a reliable and reproducible RNA extraction method is critical for generating high-quality transcriptome sequences for molecular assays. Here, the efficiency of four RNA extraction methods: Qiagen AllPrep DNA/RNA method (Method QP); Qiagen AllPrep DNA/RNA method with protocol modification on the ethanol wash step after deparaffinization (Method QE); CELLDATA RNA extraction (Method BP) and CELLDATA RNA extraction with protocol modifications on the lysis step (Method BL) was compared on 23 matching FFPE cardiac tissue specimens (n = 92).In comparing RNA quality metrics across FFPE RNA extract, nucleic acids extracted deploying Method QE and QP produced the highest RNA yield. However, Method QE outperformed Method QP as more extract from Method QE had DV 200 values above 30%. Both method BL and BP produced similar range of RNA purity and yield but more extract from Method BL had DV 200 values above 30% compared to Method BP. When accessing distribution value, Method BL outperformed Methods BP, QE, and QP as more extracts from Method BL had DV 200 values above 30% compared to other methods (P DV200
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Rochester, Rochester, Minnesota, United States of America.
- Genome Analysis Core, Medical Genome Facility, Center for Individualized Medicine, Mayo Clinic Rochester, Rochester, Minnesota, United States of America.
- Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota, United States of America.
- Division of Cardiovascular Medicine, General Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota, United States of America.
- Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester, Rochester, Minnesota, United States of America.
- Center for Regenerative Medicine, Mayo Clinic Rochester, Rochester, Minnesota, United States of America.
ORCID-Profile: Nkechi Martina Odogwu
Förderung
- Mayo Foundation for Medical Education and Research
Zitieren
APA
Odogwu, N. M., Jang, J. S., Albertson, S., Hagen, C., Rasmussen, B., Saji, O., Nelson, T. J., & Wanek Program Preclinical Pipeline (2024). Optimizing RNA extraction methods for high-throughput transcriptome sequencing of formalin-fixed paraffin-embedded cardiac tissue specimens. PLOS ONE. https://doi.org/10.1371/journal.pone.0315098
Vancouver
Odogwu NM, Jang JS, Albertson S, Hagen C, Rasmussen B, Saji O, et al. Optimizing RNA extraction methods for high-throughput transcriptome sequencing of formalin-fixed paraffin-embedded cardiac tissue specimens. PLOS ONE. 2024. doi:10.1371/journal.pone.0315098
BibTeX
@article{Odogwu2024,
author = {Odogwu, Nkechi Martina and Jang, Jin Sung and Albertson, Sabrina and Hagen, Clinton and Rasmussen, Boyd and Saji, Oommen and Nelson, Timothy J and Wanek Program Preclinical Pipeline, Wanek Program Preclinical Pipeline},
title = {Optimizing RNA extraction methods for high-throughput transcriptome sequencing of formalin-fixed paraffin-embedded cardiac tissue specimens},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0315098}
}
EUVIMED